Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020988

« Back to Dashboard

NDA 020988 describes PROTONIX IV, which is a drug marketed by Wyeth Pharms Inc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the PROTONIX IV profile page.

The generic ingredient in PROTONIX IV is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

Summary for 020988

Tradename:	PROTONIX IV
Applicant:	Wyeth Pharms Inc
Ingredient:	pantoprazole sodium
Patents:	3
Therapeutic Class:	Gastrointestinal Agents
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020988

Mechanism of Action	Proton Pump Inhibitors

Suppliers and Packaging for NDA: 020988

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PROTONIX IV	pantoprazole sodium	INJECTABLE;IV (INFUSION)	020988	NDA	Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.	0008-0923	N	0008-0923-51
PROTONIX IV	pantoprazole sodium	INJECTABLE;IV (INFUSION)	020988	NDA	Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.	0008-0923	N	0008-0923-55

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;IV (INFUSION)			Strength	EQ 40MG BASE/VIAL
Approval Date:	Mar 22, 2001	TE:	AP	RLD:	Yes
Patent:	➤ Try a Free Trial	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?	Y
Patent:	➤ Try a Free Trial	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?	Y
Patent:	➤ Try a Free Trial	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?	Y

Expired US Patents for NDA 020988

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms Inc	PROTONIX IV	pantoprazole sodium	INJECTABLE;IV (INFUSION)	020988-001	Mar 22, 2001	➤ Try a Free Trial	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.